Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children

Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut mi...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:PLoS neglected tropical diseases Ročník 9; číslo 6; s. e0003861
Hlavní autori: Kay, Gemma Louise, Millard, Andrew, Sergeant, Martin J., Midzi, Nicholas, Gwisai, Reggis, Mduluza, Takafira, Ivens, Alasdair, Nausch, Norman, Mutapi, Francisca, Pallen, Mark
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Public Library of Science 26.06.2015
Public Library of Science (PLoS)
Predmet:
ISSN:1935-2735, 1935-2727, 1935-2735
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children. Stool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T-test. Pre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline. There are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.
AbstractList Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children. Stool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T-test. Pre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline. There are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.
The role of the gut microbiome in host health is becoming clearer with better characterisation of the nutritional, biochemical and immunological function of the microbes. However, to date, there is a paucity of studies describing/ investigating the role of the gut microbiome in infection, pathology and acquired immunity in children exposed to helminths, in sub-Saharan Africa. We determined how the diversity and abundance of different gut bacteria taxonomic groups differ with age, sex and infection with the helminths parasites causing bilharzia/schistosomiasis in children aged 6 months -13 years. The parasites are controlled by treatment with the antihelminthic praziquantel (PZQ), which is associated with diarrhoea within the first 24 hours of treatment in some children. We therefore also investigated the effects of PZQ treatment on the gut microbiome of the children 12 weeks post-PZQ treatment. The composition of the gut microbiome changed with age within the 0–3 year age range and also differed significantly in abundance of the different taxonomic groups between infected and uninfected children prior to treatment with PZQ. However, the pre-treatment microbiome structure was not altered by antihelminthic treatment of infected or uninfected children. Further studies are required to investigate causality and mechanisms of interaction.
Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children.BACKGROUNDSeveral infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children.Stool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T-test.METHODSStool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T-test.Pre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline.RESULTSPre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline.There are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.CONCLUSIONSThere are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.
  Background Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children. Methods Stool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T- test. Results Pre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline. Conclusions There are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.
BackgroundSeveral infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children.MethodsStool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T-test.ResultsPre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline.ConclusionsThere are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.
Author Mduluza, Takafira
Millard, Andrew
Sergeant, Martin J.
Gwisai, Reggis
Nausch, Norman
Mutapi, Francisca
Ivens, Alasdair
Midzi, Nicholas
Pallen, Mark
Kay, Gemma Louise
AuthorAffiliation 2 National Institute of Health Research, Causeway, Harare, Zimbabwe
1 Microbiology and Infection Unit, Division of Translational and Systems Medicine, Warwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, West Midlands, United Kingdom
University of Melbourne, AUSTRALIA
3 Murewa District Hospital, Murewa, Zimbabwe
5 Insitute of Immunology and Infection Research, Centre for Immunology, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, King’s Buildings, Edinburgh, United Kingdom
4 Department of Biochemistry, University of Zimbabwe, Mount Pleasant, Harare, Zimbabwe
AuthorAffiliation_xml – name: University of Melbourne, AUSTRALIA
– name: 2 National Institute of Health Research, Causeway, Harare, Zimbabwe
– name: 4 Department of Biochemistry, University of Zimbabwe, Mount Pleasant, Harare, Zimbabwe
– name: 5 Insitute of Immunology and Infection Research, Centre for Immunology, Infection and Evolution, School of Biological Sciences, University of Edinburgh, Ashworth Laboratories, King’s Buildings, Edinburgh, United Kingdom
– name: 1 Microbiology and Infection Unit, Division of Translational and Systems Medicine, Warwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, West Midlands, United Kingdom
– name: 3 Murewa District Hospital, Murewa, Zimbabwe
Author_xml – sequence: 1
  givenname: Gemma Louise
  surname: Kay
  fullname: Kay, Gemma Louise
– sequence: 2
  givenname: Andrew
  surname: Millard
  fullname: Millard, Andrew
– sequence: 3
  givenname: Martin J.
  surname: Sergeant
  fullname: Sergeant, Martin J.
– sequence: 4
  givenname: Nicholas
  surname: Midzi
  fullname: Midzi, Nicholas
– sequence: 5
  givenname: Reggis
  surname: Gwisai
  fullname: Gwisai, Reggis
– sequence: 6
  givenname: Takafira
  surname: Mduluza
  fullname: Mduluza, Takafira
– sequence: 7
  givenname: Alasdair
  surname: Ivens
  fullname: Ivens, Alasdair
– sequence: 8
  givenname: Norman
  surname: Nausch
  fullname: Nausch, Norman
– sequence: 9
  givenname: Francisca
  surname: Mutapi
  fullname: Mutapi, Francisca
– sequence: 10
  givenname: Mark
  surname: Pallen
  fullname: Pallen, Mark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26114287$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNURD_gHyDIkcsuHsdOHA5I1dKWlYo4QM-WY0-6Xjn2EjuV-Pd4u2nV9sDJ1sw7zzuamdPiyAePRfEeyBKqBj5vwzR65ZY7n8ySEFKJGl4VJ9BWfEGbih89-R8XpzFuCeEtF_CmOKY1AKOiOSnsN9v3OKLXGEvry7TB8lKhVq78YfUYOhsG3Cd-6Y2NKcQwqHKjcFAp56ahXPsedUJTrjbWmQwq7-KyvPH2Zfxt8bpXLuK7-T0rbi4vfq--L65_Xq1X59cLzVqRFlRTJqATreJEdLoDBkybRlct5QgVMiBIOiF4TbSpdVP30EKnKoOUd0K11Vnx8cDduRDlPKUooW5rwXkDTVasDwoT1FbuRjuo8a8Mysr7QBhvpRqT1Q6lMRoaAUCEASZ4r1jb14I2lNdadx3PrK-z29QNaDT6NCr3DPo84-1G3oY7yVjGMJYBn2bAGP5MGJMcbNTonPIYpvu-KW0rwUiWfnjq9WjysM0sYAdBXlyMI_aPEiByfzQP45D7o5Hz0eSyLy_KtE0q2bDv2Lr_F_8D5H3MbQ
CitedBy_id crossref_primary_10_1371_journal_pntd_0008464
crossref_primary_10_1371_journal_pntd_0012844
crossref_primary_10_3390_pathogens9090767
crossref_primary_10_1093_trstmh_trae035
crossref_primary_10_3389_fcimb_2022_852900
crossref_primary_10_1111_pim_12949
crossref_primary_10_3389_fmicb_2020_01517
crossref_primary_10_1016_j_tim_2022_05_008
crossref_primary_10_1111_pim_12390
crossref_primary_10_1186_s40794_019_0097_5
crossref_primary_10_1016_j_ijpara_2019_12_008
crossref_primary_10_1038_s41575_018_0061_2
crossref_primary_10_1186_s12866_025_04252_5
crossref_primary_10_1080_19490976_2024_2379624
crossref_primary_10_1038_s41598_020_80537_1
crossref_primary_10_3389_fcimb_2019_00402
crossref_primary_10_1111_pim_12430
crossref_primary_10_1371_journal_pgen_1005658
crossref_primary_10_1051_parasite_2020074
crossref_primary_10_3389_fimmu_2018_03042
crossref_primary_10_1038_s41598_018_36709_1
crossref_primary_10_1093_jhered_esy014
crossref_primary_10_3389_fvets_2021_645807
crossref_primary_10_1186_s13071_024_06245_1
crossref_primary_10_1038_s41598_020_77374_7
crossref_primary_10_4049_jimmunol_1501432
crossref_primary_10_1038_s41385_022_00532_9
crossref_primary_10_1186_s40249_021_00821_8
crossref_primary_10_1007_s40588_017_0077_3
crossref_primary_10_1007_s00284_021_02718_z
crossref_primary_10_1128_MMBR_00044_18
crossref_primary_10_1038_s41598_022_23608_9
crossref_primary_10_1038_s42003_020_0859_7
crossref_primary_10_1016_S1473_3099_16_30475_3
crossref_primary_10_1016_j_pt_2017_12_007
crossref_primary_10_3389_fcell_2021_766205
crossref_primary_10_1371_journal_pntd_0006144
crossref_primary_10_1111_pim_12404
crossref_primary_10_1371_journal_pone_0212593
crossref_primary_10_1016_j_pt_2015_06_003
crossref_primary_10_3390_ijms232113358
crossref_primary_10_3389_fmicb_2021_614522
crossref_primary_10_1016_j_envint_2021_106695
crossref_primary_10_3389_fimmu_2020_593838
crossref_primary_10_3390_microorganisms12020371
crossref_primary_10_3389_fmicb_2019_00352
crossref_primary_10_1186_s40168_021_01195_7
crossref_primary_10_1038_s41598_025_91164_z
crossref_primary_10_1016_j_micpath_2024_107122
crossref_primary_10_1017_S003118201900088X
crossref_primary_10_1111_pim_12450
crossref_primary_10_1186_s40168_022_01385_x
crossref_primary_10_1371_journal_pntd_0006620
crossref_primary_10_3389_fimmu_2018_02492
crossref_primary_10_1186_s13071_018_2739_2
crossref_primary_10_1038_ismej_2016_153
crossref_primary_10_1128_IAI_00275_19
crossref_primary_10_1016_j_actatropica_2020_105524
crossref_primary_10_1016_j_diagmicrobio_2023_115954
crossref_primary_10_3390_pathogens13100906
crossref_primary_10_1007_s00436_020_06743_y
crossref_primary_10_1002_ajhb_23371
crossref_primary_10_1016_j_actatropica_2022_106578
crossref_primary_10_23736_S2724_5985_24_03799_9
crossref_primary_10_3389_fimmu_2022_941530
crossref_primary_10_1007_s00281_016_0609_6
crossref_primary_10_1371_journal_pntd_0012456
crossref_primary_10_1038_s41396_020_00868_9
crossref_primary_10_3390_microorganisms11082118
crossref_primary_10_1038_s41598_020_73827_1
crossref_primary_10_1371_journal_pntd_0005963
crossref_primary_10_1017_S0031182020000736
crossref_primary_10_1111_pim_12343
crossref_primary_10_2147_PHMT_S414766
crossref_primary_10_3390_microorganisms8122018
Cites_doi 10.1371/journal.pone.0054783
10.1371/journal.pone.0035466
10.1016/j.syapm.2008.07.001
10.1371/journal.pone.0076573
10.1016/j.cell.2012.04.037
10.1016/S0140-6736(06)69440-3
10.1126/science.1258443
10.1016/j.trstmh.2008.03.010
10.1038/pr.2014.49
10.1016/j.ijantimicag.2012.10.012
10.1371/journal.pone.0019149
10.1111/j.0105-2896.2004.00191.x
10.1371/journal.ppat.1003000
10.1371/journal.pntd.0003627
10.1017/S0031182014000699
10.1038/srep00472
10.1111/cei.12230
10.7554/eLife.01202
10.1084/jem.20091903
10.1097/00005176-200001000-00019
10.1055/s-0033-1361825
10.1016/j.ijpara.2012.11.011
10.1371/journal.pntd.0003049
10.1371/journal.pntd.0003014
10.1038/508S61a
10.1371/journal.pntd.0002880
10.1038/mi.2014.23
10.1126/science.1208344
10.1186/1757-4749-4-16
10.1371/journal.pntd.0001824
10.1371/journal.pntd.0001143
10.1021/pr900711j
10.1093/nar/gkt1209
10.4269/ajtmh.1977.26.702
10.1586/eri.10.14
ContentType Journal Article
Copyright 2015 Kay et al 2015 Kay et al
2015 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Infected Children vs. Uninfected Children. PLoS Negl Trop Dis 9(6): e0003861. doi:10.1371/journal.pntd.0003861
Copyright_xml – notice: 2015 Kay et al 2015 Kay et al
– notice: 2015 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Infected Children vs. Uninfected Children. PLoS Negl Trop Dis 9(6): e0003861. doi:10.1371/journal.pntd.0003861
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1371/journal.pntd.0003861
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Gut Microbiome Structure during Schistosome Infection in Children
EISSN 1935-2735
ExternalDocumentID 1696855717
oai_doaj_org_article_ddc1781108d1485fa49f6827256ccbb5
PMC4482744
26114287
10_1371_journal_pntd_0003861
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: Wellcome Trust
  grantid: WT082028MA
– fundername: Wellcome Trust
  grantid: 095831
GroupedDBID ---
123
29O
2WC
53G
5VS
7X7
88E
8C1
8FI
8FJ
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABUWG
ACCTH
ACGFO
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFFHD
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAIFH
BAWUL
BBTPI
BCNDV
BENPR
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAP
EAS
EBD
ECGQY
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
ITC
KQ8
M1P
M48
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PV9
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
IPNFZ
NPM
RIG
WOQ
7X8
PUEGO
5PM
-
3V.
AAPBV
ABPTK
ADACO
BBAFP
M~E
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-c498t-2c2481b89a508bcb1414cd7c3925e13e410e0b88560cd6c76f191ba3de25b8a93
IEDL.DBID DOA
ISICitedReferencesCount 84
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000357398100049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1935-2735
1935-2727
IngestDate Fri Nov 26 17:13:59 EST 2021
Tue Oct 14 19:04:18 EDT 2025
Tue Nov 04 01:57:32 EST 2025
Thu Sep 04 20:13:24 EDT 2025
Mon Jul 21 05:58:40 EDT 2025
Tue Nov 18 22:28:54 EST 2025
Sat Nov 29 01:37:56 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c498t-2c2481b89a508bcb1414cd7c3925e13e410e0b88560cd6c76f191ba3de25b8a93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Current Address: Pediatric Pneumology and Infectious Diseases Group, Department of General Pediatrics, Neonatology, and Pediatric Cardiology, University Children’s Hospital, Duesseldorf, Germany
Conceived and designed the experiments: FM TM NM NN MP. Performed the experiments: GLK NN. Analyzed the data: GLK MP MJS AM AI. Contributed reagents/materials/analysis tools: MP AI MJS AM. Wrote the paper: GLK MP FM NN. Fieldwork design and implementation: FM TM NN NM RG.
Current Address: University of Zimbabwe, College of Health Sciences, Department of Medical Microbiology, Harare, Zimbabwe
The authors have declared that no competing interests exist.
OpenAccessLink https://doaj.org/article/ddc1781108d1485fa49f6827256ccbb5
PMID 26114287
PQID 1692293840
PQPubID 23479
ParticipantIDs plos_journals_1696855717
doaj_primary_oai_doaj_org_article_ddc1781108d1485fa49f6827256ccbb5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4482744
proquest_miscellaneous_1692293840
pubmed_primary_26114287
crossref_primary_10_1371_journal_pntd_0003861
crossref_citationtrail_10_1371_journal_pntd_0003861
PublicationCentury 2000
PublicationDate 2015-06-26
PublicationDateYYYYMMDD 2015-06-26
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-06-26
  day: 26
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco, CA USA
PublicationTitle PLoS neglected tropical diseases
PublicationTitleAlternate PLoS Negl Trop Dis
PublicationYear 2015
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References RM Maizels (ref6) 2004; 201
PK Mishra (ref34) 2014; 7
P Jordan (ref17) 1993
(ref25) 2002
RM Maizels (ref7) 2014; 345
SC Lee (ref19) 2014; 8
N Nausch (ref13) 2012; 6
Y Wang (ref18) 2009; 8
R Saad (ref3) 2012; 4
L Putignani (ref40) 2014; 76
LJ Appleby (ref14) 2014; 8
M Li (ref37) 2014; 32
L Glendinning (ref4) 2014; 141
P Yarza (ref30) 2008; 31
RM Maizels (ref8) 2009; 206
KE Mott (ref27) 1983; 76
N Midzi (ref26) 2014; 8
P Yilmaz (ref32) 2014; 42
F Mutapi (ref21) 2011; 5
GD Wu (ref31) 2011; 334
N Nausch (ref12) 2012; 2
KE Fujimura (ref23) 2010; 8
ref24
AW Cheever (ref33) 1977; 26
S Caserta (ref15) 2012; 7
G Dubourg (ref2) 2013; 41
RJ Ellis (ref38) 2013; 8
H Chung (ref1) 2012; 149
F Mutapi (ref10) 2011; 6
S DeWeerdt (ref35) 2014; 508
JU Scher (ref20) 2013; 2
M Holzscheiter (ref16) 2014; 175
MJ Broadhurst (ref36) 2012; 8
HJ Harmsen (ref39) 2000; 30
N Nausch (ref11) 2015; 9
HJ McSorley (ref9) 2013; 43
ref5
N Midzi (ref22) 2008; 102
R Westram (ref29) 2011
N Katz (ref28) 1972; 14
B Gryseels (ref41) 2006; 368
P Cooper (ref42) 2013; 8
26225727 - PLoS Negl Trop Dis. 2015 Jul 30;9(7):e0003969. doi: 10.1371/journal.pntd.0003969.
References_xml – volume: 76
  start-page: 101
  year: 1983
  ident: ref27
  article-title: A reusable polyamide filter for diagnosis of S. haematobium infection by urine filtration
  publication-title: Bull Soc Pathol Exo
– ident: ref5
– volume: 8
  start-page: e54783
  year: 2013
  ident: ref38
  article-title: Comparison of the distal gut microbiota from people and animals in Africa
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0054783
– volume: 7
  start-page: e35466
  year: 2012
  ident: ref15
  article-title: Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0035466
– volume: 14
  start-page: 397
  year: 1972
  ident: ref28
  article-title: A simple device for quantitative stool thick smear technique in schistosomiasis mansoni
  publication-title: Rev Instit Med Trop Sao Paulo
– volume: 31
  start-page: 241
  year: 2008
  ident: ref30
  article-title: The All-Species Living Tree project: a 16S rRNA-based phylogenetic tree of all sequenced type strains
  publication-title: Syst Appl Microbiol
  doi: 10.1016/j.syapm.2008.07.001
– volume: 8
  start-page: e76573
  year: 2013
  ident: ref42
  article-title: Patent human infections with the whipworm, Trichuris trichiura, are not associated with alterations in the faecal microbiota
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0076573
– volume: 149
  start-page: 1578
  year: 2012
  ident: ref1
  article-title: Gut immune maturation depends on colonization with a host-specific microbiota
  publication-title: Cell
  doi: 10.1016/j.cell.2012.04.037
– volume: 368
  start-page: 1106
  year: 2006
  ident: ref41
  article-title: Human schistosomiasis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)69440-3
– volume: 345
  start-page: 517
  year: 2014
  ident: ref7
  article-title: Immunology. How helminths go viral
  publication-title: Science
  doi: 10.1126/science.1258443
– volume: 102
  start-page: 759
  year: 2008
  ident: ref22
  article-title: Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe
  publication-title: Trans R Soc Trop Med Hyg
  doi: 10.1016/j.trstmh.2008.03.010
– volume: 76
  start-page: 2
  year: 2014
  ident: ref40
  article-title: The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood
  publication-title: Pediatr Res
  doi: 10.1038/pr.2014.49
– ident: ref24
– volume: 41
  start-page: 149
  year: 2013
  ident: ref2
  article-title: High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2012.10.012
– year: 2011
  ident: ref29
  article-title: Handbook of Molecular Microbial Ecology I: Metagenomics and Complementary Approaches
– volume: 6
  start-page: e19149
  year: 2011
  ident: ref10
  article-title: Schistosome infection intensity is inversely related to auto-reactive antibody levels
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019149
– volume: 201
  start-page: 89
  year: 2004
  ident: ref6
  article-title: Helminth parasites—masters of regulation
  publication-title: Immunol Rev
  doi: 10.1111/j.0105-2896.2004.00191.x
– volume: 8
  start-page: e1003000
  year: 2012
  ident: ref36
  article-title: Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003000
– volume: 9
  start-page: e0003627
  year: 2015
  ident: ref11
  article-title: Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0003627
– volume: 141
  start-page: 1255
  year: 2014
  ident: ref4
  article-title: The microbiota and helminths: sharing the same niche in the human host
  publication-title: Parasitology
  doi: 10.1017/S0031182014000699
– volume: 2
  start-page: 472
  year: 2012
  ident: ref12
  article-title: Proportions of CD4+ memory T cells are altered in individuals chronically infected with Schistosoma haematobium
  publication-title: Sci Rep
  doi: 10.1038/srep00472
– volume: 175
  start-page: 246
  year: 2014
  ident: ref16
  article-title: Lack of host gut microbiota alters immune responses and intestinal granuloma formation during schistosomiasis
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12230
– volume: 2
  start-page: e01202
  year: 2013
  ident: ref20
  article-title: Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis
  publication-title: Elife
  doi: 10.7554/eLife.01202
– volume: 206
  start-page: 2059
  year: 2009
  ident: ref8
  article-title: Regulation of pathogenesis and immunity in helminth infections
  publication-title: J Exp Med
  doi: 10.1084/jem.20091903
– volume: 30
  start-page: 61
  year: 2000
  ident: ref39
  article-title: Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/00005176-200001000-00019
– volume: 32
  start-page: 74
  year: 2014
  ident: ref37
  article-title: Early development of the gut microbiome and immune-mediated childhood disorders
  publication-title: Semin Reprod Med
  doi: 10.1055/s-0033-1361825
– volume: 43
  start-page: 301
  year: 2013
  ident: ref9
  article-title: Immunomodulation by helminth parasites: defining mechanisms and mediators
  publication-title: Int J Parasitol
  doi: 10.1016/j.ijpara.2012.11.011
– volume: 8
  start-page: e3049
  year: 2014
  ident: ref14
  article-title: CD16 expression on monocytes in healthy individuals but not schistosome-infected patients Is positively associated with levels of parasite-specific IgG and IgG1
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0003049
– volume: 8
  start-page: e3014
  year: 2014
  ident: ref26
  article-title: Distribution of schistosomiasis and soil transmitted helminthiasis in zimbabwe: towards a national plan of action for control and elimination
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0003014
– volume: 508
  start-page: S61
  year: 2014
  ident: ref35
  article-title: Microbiome: A complicated relationship status
  publication-title: Nature
  doi: 10.1038/508S61a
– volume: 8
  start-page: e2880
  year: 2014
  ident: ref19
  article-title: Helminth colonization is associated with increased diversity of the gut microbiota
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0002880
– volume: 7
  start-page: 753
  year: 2014
  ident: ref34
  article-title: Systemic impact of intestinal helminth infections
  publication-title: Mucosal Immunol
  doi: 10.1038/mi.2014.23
– volume: 334
  start-page: 105
  year: 2011
  ident: ref31
  article-title: Linking long-term dietary patterns with gut microbial enterotypes
  publication-title: Science
  doi: 10.1126/science.1208344
– volume: 4
  start-page: 16
  year: 2012
  ident: ref3
  article-title: Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes
  publication-title: Gut Pathog
  doi: 10.1186/1757-4749-4-16
– volume: 6
  start-page: e1824
  year: 2012
  ident: ref13
  article-title: Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0001824
– volume: 5
  start-page: e1143
  year: 2011
  ident: ref21
  article-title: Schistosoma haematobium treatment in 1–5 year old children: safety and efficacy of the antihelminthic drug praziquantel
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0001143
– year: 1993
  ident: ref17
  article-title: Human Schistosomiasis
– volume: 8
  start-page: 5442
  year: 2009
  ident: ref18
  article-title: Systems metabolic effects of a necator americanus infection in Syrian hamster
  publication-title: J Proteome Res
  doi: 10.1021/pr900711j
– year: 2002
  ident: ref25
  article-title: Prevention and control of schistosomiasis and soil-transmisted helminthiasis
– volume: 42
  start-page: D643
  year: 2014
  ident: ref32
  article-title: The SILVA and "All-species Living Tree Project (LTP)" taxonomic frameworks
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkt1209
– volume: 26
  start-page: 702
  year: 1977
  ident: ref33
  article-title: Schistosoma mansoni and S. haematobium infections in Egypt. II. Quantitative parasitological findings at necropsy
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.1977.26.702
– volume: 8
  start-page: 435
  year: 2010
  ident: ref23
  article-title: Role of the gut microbiota in defining human health
  publication-title: Expert Rev Anti Infect Ther
  doi: 10.1586/eri.10.14
– reference: 26225727 - PLoS Negl Trop Dis. 2015 Jul 30;9(7):e0003969. doi: 10.1371/journal.pntd.0003969.
SSID ssj0059581
Score 2.429898
Snippet Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children...
The role of the gut microbiome in host health is becoming clearer with better characterisation of the nutritional, biochemical and immunological function of...
BackgroundSeveral infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome...
  Background Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut...
SourceID plos
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0003861
SubjectTerms Age
Animals
Child
Diarrhea
Dysbiosis - etiology
Dysbiosis - pathology
Feces - microbiology
Funding
High-Throughput Nucleotide Sequencing
HIV
Human immunodeficiency virus
Humans
Immunology
Infections
Infectious diseases
Microbiota - genetics
Multivariate Analysis
Parasites
Pathology
Phylogeny
Praziquantel - therapeutic use
RNA, Ribosomal, 16S - genetics
Schistosomiasis haematobia - complications
Schistosomiasis haematobia - drug therapy
Schistosomiasis haematobia - microbiology
Studies
Taxonomy
Tropical diseases
SummonAdditionalLinks – databaseName: Public Library of Science (PLoS) Journals Open Access
  dbid: FPL
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bSxwxFA5FS-lL1drWaVVS8HW2k0xu89iqSwsqQm3xbchtcMCdFWfX39-TTHbbXZTi25ALE05Oku_j5HxB6KggjfeK2Fw6w3NGdJGHlrkQWjjhaFPGXJjfZ_LiQl1fV5d_ieJaBL-U5Euy6eium7lRjGQFtrNJSyEC2Rpfni12Xl5xRVJ63FM9V46fqNIfVE1vp_1jCHP9ouQ_J89467lj3kZvEsbEXwen2EEvfPcWvTpPUfRd1J6kV1Fgj8BthwED4rH2MFv4vB2EmSY-VPy0UY64n040vtFB3RXq5hP8I97g8g4fp1Rw_NCPMMDX9fJ36Nf49Or4e56eXMgtq9Qsp5YyALKq0gDcjDWEEWadtICiuCelZ6TwhVEKcJJ1wkrRAN8zunSecqN0Vb5HG92083sIM2kb0wigK4VhjME3rwpXmZIJb6k2GSoXM1HbpEcensW4rWOQTQIvGcxVByvWyYoZype97gY9jv-0_xYmedk2qGnHApiuOi3O2jlLQsZtoRywQ95oVjVCUQlw0FpjeIb2gossftDXJEgKcQ5UOEOfF25Tw8IM0Rbd-ek8tqGApYBAZ-jD4EbLUQBtDUp30FuuONjKMFdruvYmin-zoNvK2Menh_QJvQZUx8N9Nir20cbsfu4P0Ev7MGv7-8O4Yv4AKxgZTg
  priority: 102
  providerName: Public Library of Science
Title Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
URI https://www.ncbi.nlm.nih.gov/pubmed/26114287
https://www.proquest.com/docview/1692293840
https://pubmed.ncbi.nlm.nih.gov/PMC4482744
https://doaj.org/article/ddc1781108d1485fa49f6827256ccbb5
http://dx.doi.org/10.1371/journal.pntd.0003861
Volume 9
WOSCitedRecordID wos000357398100049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1935-2735
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0059581
  issn: 1935-2735
  databaseCode: DOA
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1935-2735
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0059581
  issn: 1935-2735
  databaseCode: 7X7
  dateStart: 20071001
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1935-2735
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0059581
  issn: 1935-2735
  databaseCode: BENPR
  dateStart: 20071001
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1935-2735
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0059581
  issn: 1935-2735
  databaseCode: 8C1
  dateStart: 20071001
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1935-2735
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0059581
  issn: 1935-2735
  databaseCode: PIMPY
  dateStart: 20071001
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVATS
  databaseName: Public Library of Science (PLoS) Journals Open Access
  customDbUrl:
  eissn: 1935-2735
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0059581
  issn: 1935-2735
  databaseCode: FPL
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: http://www.plos.org/publications/
  providerName: Public Library of Science
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ba9swFBZbN8Zeyu71LkGDvTq1bN382GYNKzTB7Eb2ZHQzNTROqZP-_h3JSmjKoC97EUYXLOkcSd9BOt9B6EtGGuckMamwmqWUqCz1NVPOFbfc5k0RfGF-X4j5XC4WZXUn1Jd_EzbQAw8Td2ytId4bMpMWkDtrFC0bLnMBR7UxWgf20kyUW2Nq2INZyUJ4UkAn3uMqF9FprhDkOMpofN2t7TjcjHGydygF7n7PdXq16v-FO-8_n7xzHk1foMMIJPHJMICX6JHrXqFns3hV_hq1X2PoE9gIcNthAHp4qhyIBM_agX1p6XzBDxM4h_vVUuFL5SlcoWyzxOfhmZazeBL9vfFtP8aAUe_nv0G_pmc_J9_SGFchNbSU6zQ3OQW0KksF6EwbTSihxgoDUIk5UjhKMpdpKQEMGcuN4A0YdVoV1uVMS1UWb9FBt-rcEcJUmEY3HGySTFNK4ZuVmS11QbkzudIJKrYTW5tIOu5jX1zV4SZNgPExTFftxVFHcSQo3bW6Hkg3Hqh_6mW2q-sps0MGKFIdFal-SJESdOQlvv1BXxPPG8QY2LsJ-rzVghpWn79SUZ1bbUKdHAATWMkJejdoxa4XYJt6OjtoLfb0Za-b-yVdexkYvqknZ6X0_f8Y1wf0HEAe88_bcv4RHaxvNu4Tempu121_M0KPxUKEVEIqJ2SEnpyezavvo7CgIJ1WF5BXnc-qP38BBOcldA
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQQcCFd2l4Golrljjx8wiFVSt2V5UoqLfIr6iRutmq2e3vZ-w4K7ai4sItiseKM-PE36fxfEboY0Ea7yWxuXCG5ZToIg-WOeeaO-7Kpoq1ML9mYrGQZ2fqJEkKhVqY5EHgiBerPmbyw8Wq85-SJ4fE6YRUgozGk8tu7SYxyRWI0F2hYBEKio8ns_GnzBSTJFXO3dZzZ2WKAv5B8BSe_jfweXMP5R-L0vTxf3ydJ-hRQqb489DjKbrju2fo_jzl3p-j9ms6SwX-LLjtMCBHPNUeYozn7SDntPSh4YeNIsb9aqnxuQ6asNC2WeLjuO_LO3yYCsjxdT_BAHpv3n-Bfk6_nR4e5emghtxSJdd5aUsK8FcqDXDPWEMoodYJC9iLeVJ5SgpfGCkBXVnHreANsESjK-dLZqRW1T7a68ApBwhTYRvTcCA5haGUwjVThVOmotzbUpsMVWOQaptUzMNhGhd1TM0JYDODu-rgxTp5MUP5ttfloOLxD_svIf5b26DBHW9ABOsUudo5S0KdbiEdcErWaKoaLksBINJaY1iGDkKwxwf0NQlCRIwBgc7Qh3FG1fA5hxyN7vxqE21KQGBAuzP0cphh21EA2Q36eNBb7My9nWHutnTteZQMp0HtldJXtw_pPXpwdDqf1bPjxffX6CHgQhZ2xJX8DdpbX238W3TPXq_b_upd_LB-A0IWMjo
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLZKQRUX9tKwGglxyzROvOUILSMqpqORWNQLirxFjdTJVE2mv59nxxkxFRUnbpGXxHl-Sb4vz-8zQu8zUjsniUmF1SylRGWpb5lyrrjlNq-LkAvzcybmc3l2Vi520K8xFyZaEDjixaoLkXx_sGrdYbTkodcrGqKnE1IIMvaYXLa9nYRIFycfguKQ_zPW-wSkO-iuKIHKeBXIxWx8UbOSSRKz6W470dbXKoj6exFUGNHfAOnNdZV_fKimD__zLT5CDyKCxR-HszxGO659gvZOY4z-KWqO454r8AbCTYsBYeKpcuAL-LQZZJ-Wzld8M0HsuFstFT5XXjsW6tZLfBLWhzmLj2KiOb7uJhjA8c3yZ-jH9PP3oy9p3NAhNbSUfZqbnAJMlqUCWKiNJpRQY4UBjMYcKRwlmcu0lIDCjOVG8BrYpFaFdTnTUpXFPtptwVAHCFNhal1zIEOZppTCMSszW-qCcmdypRNUjBNXmah27jfduKhCCE8A6xnMVXmjVtGoCUo3vS4HtY9_tP_kfWLT1mt1hwKY1SrOZmWtIT6fN5MWuCerFS1rLnMBYNMYrVmCDrwDjBfoKuIFixgDop2gd6OXVfDY-1iOat1qHdrkgNSAnifo-eB1m1EAKfY6etBbbPnj1jC3a9rmPEiLU68KS-mL24f0Fu0tjqfV7GT-9SW6D_CR-YVzOX-FdvurtXuN7pnrvumu3oRn7TeNqEFv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differences+in+the+Faecal+Microbiome+in+Schistosoma+haematobium+Infected+Children+vs.+Uninfected+Children&rft.jtitle=PLoS+neglected+tropical+diseases&rft.au=Gemma+Louise+Kay&rft.au=Andrew+Millard&rft.au=Martin+J+Sergeant&rft.au=Nicholas+Midzi&rft.date=2015-06-26&rft.pub=Public+Library+of+Science+%28PLoS%29&rft.issn=1935-2727&rft.eissn=1935-2735&rft.volume=9&rft.issue=6&rft.spage=e0003861&rft_id=info:doi/10.1371%2Fjournal.pntd.0003861&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_ddc1781108d1485fa49f6827256ccbb5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1935-2735&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1935-2735&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1935-2735&client=summon